During the past decade, UZ Leuven Sint Rafael conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on
average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable
2018-05-15
2023-05-02
Active, not recruiting
463
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UZ Leuven Sint Rafael" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Amgen" with 1 trials
sponsored, "Eli Lilly and Company" with 1 trials sponsored, "HAL Allergy" with 1 trials sponsored and "Santhera Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Leuven Sint Rafael"
#1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UZ Leuven Sint Rafael
According to Clinical.Site data, the most researched conditions in "UZ Leuven Sint Rafael" are
"Geographic Atrophy" (3 trials), "Allergic Rhinitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Atopic Dermatitis" (1 trials) and "Leber's Hereditary Optic Neuropathy (LHON)" (1 trials). Many other conditions were trialed in "UZ Leuven Sint Rafael" in a lesser frequency.
Clinical Trials Intervention Types at UZ Leuven Sint Rafael
Most popular intervention types in "UZ Leuven Sint Rafael" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (3 trials), "Placebo" (2 trials), "Apremilast" (1 trials), "Baricitinib" (1 trials) and "Idebenone" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UZ Leuven Sint Rafael
The vast majority of trials in "UZ Leuven Sint Rafael" are
7 trials for "All" genders.
Clinical Trials Status at UZ Leuven Sint Rafael
Currently, there are NaN active trials in "UZ Leuven Sint Rafael".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in UZ Leuven Sint Rafael,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in UZ Leuven Sint Rafael, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".